KLOW 80 mg is a research blend of four research compounds, BPC-157, TB-500, GHK-Cu and KPV, supplied for laboratory research only. It builds on the GLOW blend (BPC-157, TB-500, GHK-Cu) by adding KPV.
Composition (per vial)
- GHK-Cu (50 mg): Studied for collagen synthesis and tissue-remodelling gene expression.
- BPC-157 (10 mg): Studied in preclinical tissue repair and gastrointestinal models.
- TB-500 (10 mg): A thymosin beta-4 fragment studied for cell migration and angiogenesis.
- KPV (10 mg): A research compound studied for inflammatory signalling through NF-κB.
Research Areas
Researchers study this combination in preclinical models of tissue repair, inflammatory signalling, extracellular matrix remodelling and wound biology. Findings from individual components are predominantly preclinical and should not be extrapolated to humans.
Format
Lyophilised (freeze-dried) powder, 80 mg total per vial.
Storage
Store the lyophilised powder in a cool, dark place, or refrigerate at 2°C to 8°C. Once reconstituted with bacteriostatic water, keep chilled and use within the recommended laboratory timeframe.
For laboratory and research purposes only. Not for human consumption, medical use, or veterinary use.
